vimarsana.com

Page 4 - பாரிஸ் வணிகரீதியானது நீதிமன்றம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Postcard from abroad: Charlotte Gerrish, Gerrish Legal

2CRSi SA: Additional information about Blade

2CRSi SA: Additional information about Blade. DJ 2CRSi SA: Additional information about Blade. 2CRSi SA 2CRSi SA: Additional information about Blade. 11-March-2021 / 18:11 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. = Press release Additional information about Blade Strasbourg (France), 11 March 2021 - 2CRSi (ISIN: FR0013341781), a designer and manufacturer of high-performance, energy-efficient IT servers, provides additional information to its shareholders regarding the Blade company and the ongoing legal proceedings. Update on Blade SAS As announced on 3 March, Blade SAS, the specialist of cloud PC for video game players, has been placed in receivership

The China International Commercial Court | White & Case LLP

To embed, copy and paste the code into your website or blog: To provide judicial support for the Belt & Road Initiative ( BRI ), the Supreme People s Court of the People s Republic of China ( Supreme Court ) launched two international commercial courts ( China International Commercial Court or CICC ) 1 in June 2018, which are respectively based in the southern Chinese city Shenzhen and the northern city Xi an. 2 The establishment of CICC is a ground-breaking innovation for the judiciary system in China, and may have a profound impact on the resolution of cross-border disputes arising from international commercial transactions connected to the BRI. Since their foundation, these courts have administered more than a dozen of cases. The Supreme Court has issued several judicial documents to guide the operation of CICC, such as the Provisions on Several Issues regarding the Establishment of the CICC,

Continuation of the business combination project between Pixium Vision et Second Sight Medical Products

Continuation of the business combination project between Pixium Vision et Second Sight Medical Products Second Sight ») (Nasdaq: EYES) continues under the terms announced to the market on January 6, 2021. The company is working with Second Sight to satisfy the closing conditions to the combination, which is currently anticipated to be completed during the second quarter of 2021. In addition, the President of the Paris Commercial Court has appointed, by order dated January 18, 2021, Mr. Olivier Péronnet and Mr. Gilles de Courcel as contribution appraiser, whose conclusions will be made available to the Pixium Vision s shareholders. As a reminder, the completion of the transaction is notably subject to the following conditions precedent:

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.